|
WO2015179490A1
|
|
Treatment of diseases and conditions caused by increased vascular permeability
|
|
US2015166951A1
|
|
Cell-derived composition
|
|
US2015150915A1
|
|
Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
|
|
US2015079190A1
|
|
Immortalized cell compositions and compositions derived therefrom
|
|
US2015202235A1
|
|
Amnion-derived cell compositions, methods of making and uses thereof
|
|
US2015050251A1
|
|
Cosmetic Preparations
|
|
US2015051147A1
|
|
Methods for treating hidradenitis suppurativa
|
|
US2014341860A1
|
|
Methods for treating cartilage disorders, diseases, and injuries
|
|
US2014271910A1
|
|
Methods for treating urushiol-induced contact dermatitis
|
|
US2014255355A1
|
|
Methods for treating blepharitis
|
|
US2014255904A1
|
|
Modulating ischemic injury and preserving/storing tissue
|
|
US2014242040A1
|
|
Methods for preventing and/or treating nasal polyps and rhinosinusitis
|
|
US2014242042A1
|
|
Methods for preventing and treating hemorrhoids
|
|
US2014242043A1
|
|
Methods for preventing or treating optic neuritis
|
|
US2014242041A1
|
|
Methods for preventing or treating necrotizing enterocolitis
|
|
US2014037591A1
|
|
Methods for reducing and/or preventing excessive cellular apoptosis
|
|
CA2882186A1
|
|
Novel cell compositions and methods
|
|
US2013195842A1
|
|
Methods for treating disorders of amino acid metabolism
|
|
US2013183387A1
|
|
Methods for treating pustular psoriasis
|
|
US2013183654A1
|
|
Compositions and methods for modulating ischemic injury
|
